Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MDCX is expected to report earnings to fall 77.68% to -25 cents per share on March 30
Q4'25
Est.
$-0.25
Q3'25
Missed
by $0.90
Q2'25
Missed
by $0.18
The last earnings report on November 14 showed earnings per share of -112 cents, missing the estimate of -21 cents. With 24.89K shares outstanding, the current market capitalization sits at 26.83M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MDCX showed earnings on November 14, 2025. You can read more about the earnings report here.